RNF121 Inhibits Angiogenic Growth Factor Signaling by Restricting Cell Surface Expression of VEGFR-2

Armin Maghsoudlou1, Rosana D Meyer1, Kobra Rezazadeh1

  • 1Department of Pathology and Laboratory Medicine, Boston University Medical Campus, Boston, MA 02118, USA.

Insights

Ring Finger Protein 121 (RNF121) regulates vascular endothelial growth factor receptor-2 (VEGFR-2) maturation in the endoplasmic reticulum. RNF121 controls VEGFR-2 cell surface levels, impacting endothelial cell proliferation and angiogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Receptor Tyrosine Kinases (RTKs) are crucial for cell signaling but their downregulation mechanisms, particularly trafficking in the ER/Golgi, remain unclear.
  • Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) is a key RTK in angiogenesis, essential for both normal and pathological processes.

Purpose of the Study:

  • To investigate the role of Ring Finger Protein 121 (RNF121) in the endoplasmic reticulum (ER) mediated maturation and trafficking of VEGFR-2.
  • To elucidate the impact of RNF121 on VEGFR-2 cell surface expression and its downstream signaling in angiogenesis.

Main Methods:

  • Utilized overexpression and shRNA-mediated knockdown of RNF121 in endothelial cells.
  • Assessed VEGFR-2 ubiquitination, maturation, and cell surface levels.
  • Examined the functional requirement of the RING Finger domain of RNF121.
  • Evaluated the effects of RNF121 on VEGF-induced endothelial cell proliferation and angiogenesis.

Main Results:

  • RNF121, an ER ubiquitin E3 ligase, recognizes and regulates VEGFR-2 maturation.
  • Overexpression of RNF121 increased VEGFR-2 ubiquitination, reduced its maturation, and decreased cell surface presence.
  • RNF121 knockdown decreased VEGFR-2 ubiquitination and increased its cell surface levels.
  • The RING Finger domain of RNF121 is essential for its regulatory activity on VEGFR-2.

Conclusions:

  • RNF121 is identified as a critical regulator of VEGFR-2 trafficking and maturation within the ER.
  • RNF121 restricts VEGFR-2 cell surface abundance, thereby inhibiting VEGF-induced endothelial cell proliferation and angiogenesis.
  • RNF121 acts as a key determinant in controlling angiogenic signaling pathways.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K